Frontiers in Cardiovascular Medicine (Jun 2022)

Case Report: Severe Peripartum Cardiac Disease in Myotonic Dystrophy Type 1

  • Georgia Besant,
  • Pierre R. Bourque,
  • Pierre R. Bourque,
  • Ian C. Smith,
  • Sharon Chih,
  • Sharon Chih,
  • Mariana M. Lamacie,
  • Mariana M. Lamacie,
  • Ari Breiner,
  • Ari Breiner,
  • Jocelyn Zwicker,
  • Jocelyn Zwicker,
  • Hanns Lochmüller,
  • Hanns Lochmüller,
  • Hanns Lochmüller,
  • Jodi Warman-Chardon,
  • Jodi Warman-Chardon,
  • Jodi Warman-Chardon

DOI
https://doi.org/10.3389/fcvm.2022.899606
Journal volume & issue
Vol. 9

Abstract

Read online

BackgroundMyotonic dystrophy type 1 (DM1) is a hereditary muscular dystrophy affecting ∼2.1–14.3/100,000 adults. Cardiac manifestations of DM1 include conduction disorders and rarely cardiomyopathies. DM1 increases the risk of obstetric complications, however, little is known about the relationship between pregnancy and cardiomyopathy in DM1 due to disease rarity.CaseA 23-year-old with DM1 developed cardiomyopathy during pregnancy. Despite initial medical stabilization, she subsequently developed multiple spontaneous coronary artery dissections postpartum, worsening cardiomyopathy and multiorgan failure. She died 5 months postpartum.ConclusionThough cardiomyopathy and arterial dissection are both known complications of pregnancy, this case suggests individuals with myotonic dystrophy type 1 may be at heightened risk for cardiac disease during the peripartum period. Physicians caring for women with suspected or proven DM1 should offer counseling and be alerted to the risk of cardiac complications with pregnancy and in the peripartum period. Pregnant and peripartum women with DM1 are likely to benefit from more frequent assessments of cardiac function including echocardiograms and early institution of heart failure management protocols when symptoms of cardiomyopathy present.

Keywords